Symbiotic, the collateral markets platform backed by Paradigm, Pantera Capital, cyber•Fund, and Coinbase Ventures, has announced the integration of Symbiotic Liquid Lane, an instant USDC liquidity facility, with Centrifuge, the leading tokenization and onchain asset management platform.

The integration supports tokenized funds issued through Centrifuge that together cover the platform's $1.6 billion in assets under management: JAAA, Janus Henderson's AAA-rated CLO strategy; HYB, New York Life Investment Management's tokenized U.S. high-yield bond strategy; and JTRSY, Janus Henderson's short duration treasury strategy. Symbiotic Liquid Lane gives eligible holders immediate access to redemptions in USDC, the U.S. dollar-pegged stablecoin issued by Circle, accelerating JAAA and JTRSY from T+1 — settlement one business day after a redemption request — and HYB from T+3–T+5. JAAA in particular has ranked among the largest tokenized funds on public blockchains since early 2025, when its onchain assets crossed $1 billion.

Rather than locking capital into product-specific pools, Liquid Lane allows the same shared capital base to support multiple tokenized funds. That capital can remain productively deployed across approved onchain lending markets between transactions and be recalled as liquidity demand arises, making the model more capital-efficient and scalable across issuers and asset classes.

As tokenized markets mature, the infrastructure around issued assets is expanding to support more ways for investors to hold, exchange, finance, and deploy them. Major asset managers including BlackRock and Franklin Templeton already issue tokenized money-market funds on public blockchains, and the surrounding service layer — collateral markets, financing, and redemption rails — is being built out alongside them. By extending one shared liquidity layer across short-term U.S. Treasuries, AAA-rated CLOs, and U.S. high-yield corporate bonds, Symbiotic and Centrifuge are demonstrating how tokenized funds can become more flexible across onchain markets, supporting broader institutional use and adoption.

"Existing liquidity models dedicate capital to product-specific pools, while Symbiotic Liquid Lane allows the same capital base to support a range of RWAs and earn through multiple strategies between settlement events," said Misha Putiatin, co-founder of Symbiotic, in a written statement. "By bringing instant liquidity to a portfolio of this scale, spanning institutional managers and asset classes, Symbiotic and Centrifuge are moving beyond bespoke, fund-by-fund solutions toward a scalable model that can make immediate exits a standard feature of tokenized markets," he added.

Expanding Liquidity for Institutional Tokenized Assets

Tokenized assets are increasingly moving into institutional markets, but liquidity remains a major constraint on their broader use. Redemption periods for some private-credit and structured products can extend to 90 days, contributing to low capital utilization: BitMart research found that less than 10% of tokenized RWA value is actively deployed across DeFi lending and collateral markets.

Centrifuge's 2026 Tokenization Outlook reinforces the importance of solving this gap: 67% of surveyed industry operators identified reliable liquidity and redemption as the most important factor in building confidence among end investors. By giving eligible holders immediate access to USDC while the underlying redemption continues in parallel, Liquid Lane makes tokenized funds easier to finance, pledge, and redeploy across onchain markets.

"Centrifuge has long focused on bringing real-world assets onchain, and our partnership with Symbiotic brings instant liquidity to those assets," said Bhaji Illuminati, CEO of Centrifuge, in a written statement. "Giving investors confidence in the asset and its exit path through reliable redemption infrastructure is critical to scaling tokenized markets. Symbiotic helps solve a key bottleneck for RWAs, making tokenized assets easier to hold, distribute, and use across onchain markets," she added.

By combining immediate holder liquidity with existing fund operations, Symbiotic and Centrifuge are expanding how institutional tokenized funds can move through onchain collateral, financing, and treasury markets. For now, instant redemptions apply to eligible holders; extending the shared-capital model across additional issuers and asset classes is the scaling question the partnership is designed to address.

Source: Metaverse Post